Author: Rishi Sharma

Good news! We're simplifying how temperature data is reported. Beginning Monday, July 13, 2026, vaccine coordinators using PDPH-issued digital data loggers (DDLs) will now submit routine temperature data through PhilaVax only. Click the button below to view the updated temperature reporting guide. View the updated guide!...

Registration is now open for the Philadelphia Immunization Coalition (PIC) stakeholder roundtable — click the button below to register! This event can accommodate up to 30 participants. Join leaders from healthcare, community organizations, public health, and partner sectors for a discussion on strengthening immunization efforts across...

Mark your calendars! The Philadelphia Immunization Coalition (PIC) is convening a group of vaccination advocates and partners from across Philadelphia for an in-person roundtable discussion to strengthen collaboration on citywide vaccination efforts. The event will take place on Tuesday, June 30, 2026, from 9 - 11 a.m.This discussion will...

The Philadelphia Department of Public Health (PDPH) will be performing essential system maintenance on the secure FTP website tomorrow, May 8, from 5:00 p.m. to 8:00 p.m. EST. During this three-hour window, the file transfer application will be temporarily unavailable. We apologize for any inconvenience. ...

The Philadelphia Vaccines for Children (VFC) and the Vaccines for Adults at Risk (VFAAR) annual re-enrollment period is now open! To continue participating, all clinics must submit required forms by June 1, 2026. Clinics enrolled in both programs must complete separate re-enrollments for each program. Complete re-enrollment in 3...

Influenza test positivity in Philadelphia has fallen to below 3% for both influenza A and B, indicating the end of influenza season. Therefore, the Philadelphia Department of Public Health recommends stopping influenza immunization for all eligible patients. Vaccination against influenza may continue based on clinical judgment.  Unused vaccines may...

Based on decreased RSV test positivity and pediatric hospitalizations, the Philadelphia Department of Public Health recommends stopping RSV monoclonal antibody immunization (i.e., nirsevimab and clesrovimab) to all eligible patients on April 15, 2026. Administration may continue until April 30, 2026, based on clinical judgment. Due to...

Re-Enrollment Opens May 1, 2026 The Philadelphia Vaccines for Children (VFC) and the Vaccines for Adults at Risk (VFAAR) annual re-enrollment period will take place May 1 - 31, 2026 using PhilaVax. Complete the steps below to prepare for re-enrollment.  Prepare for Re-Enrollment Make sure all required staff have...

Increased disease activity indicates season extension The Philadelphia Department of Public Health recommends offering RSV monoclonal antibody immunization (i.e., nirsevimab and clesrovimab) to all eligible patients until April 15, 2026 due to continued RSV hospitalizations.  Federally purchased RSV immunization will no longer be available to order after...

Set Up Multi-Factor Authentication The secure file transport portal (SFTP), is a secure web-based application that acts as a conduit for secure communications and exchange of data between providers and the Philadelphia Department of Public Health (PDPH).We are writing to inform you of an upcoming security...

Nationally, COVID-19 activity is increasing from low levels. Continuing to vaccinate is important in protecting vulnerable individuals, such as infants, against the disease. Infants and children between 6 months and 23 months of age are at high risk of severe COVID-19. Children with certain medical conditions, such as asthma and congenital...

There are no changes in vaccine recommendations and availability in Philadelphia.  On Monday, January 5, 2026, the Centers for Disease Control and Prevention (CDC) updated the pediatric immunization schedule, changing several routine childhood vaccines from a routine recommended category to a shared-decision-making and/or high-risk category. Despite these...

RSV activity is elevated in many areas of the country, including Pennsylvania and Philadelphia. RSV (respiratory syncytial virus) immunization remains the most effective protection against RSV illness. A recent study showed that nirsevimab was 81% effective against RSV-associated hospitalization among infants younger than 6 months. Refer to these previous messages regarding availability and...

There is increasing influenza disease activity in parts of the U.S. The most recent weekly CDC influenza surveillance report shows one influenza-associated pediatric death, bringing the 2025-2026 season total to nine reported influenza-related pediatric deaths. CDC estimates that there have been at least 11,000,000 illnesses,...

The hepatitis B vaccine has saved millions of lives. Since its implementation in 1991, hepatitis B vaccination at birth has reduced pediatric hepatitis B infections by 99%.When discussing hepatitis B vaccination with patients, especially the hepatitis B birth dose, frame the choice clearly: the hepatitis B vaccine...

All Philadelphia providers enrolled in the VFC Program are eligible. What is PA CARES?  The Pennsylvania Children's Access to Routine and Essential Shots (PA CARES) program is a new state-directed initiative designed to support Vaccines for Children (VFC) providers enrolled in and in good standing with the...

The vaccine distribution center will have reduced delivery capacity during the holiday season. Orders submitted during this time will take longer than usual to ship. December: Place your order by Tuesday, December 9, 2025, at 12 p.m. Orders placed after this date may not ship until January...

The health department has recently identified a varicella (chickenpox) outbreak in a school and is sharing clinical reminders on the diagnosis and management of varicella. Varicella is a highly contagious disease that can be serious for non-immune pregnant people, newborns, and those with weak immune...